Advanced Cell Separation Technology from Clinical Sources
BioCep has developed an advanced platform for cell separation. Its patented Cell Enrichment Process (CEP), yields larger, purer and less damaged cell populations in comparison with existing technologies, setting a new standard in cell separation. The CEP can be applied in numerous medical processes, bringing exceptional benefits to each. BioCep is currently developing applications in non-invasive prenatal testing and stem cell separation, based on its advanced technology.
BioCep is committed to the development of innovative technologies and applications based on cell separation from clinical sources. The company will market its CEP system to medical research laboratories as well as diagnostic kits suitable for use with the system.
CEP can be applied in various clinical applications such as:
Non-invasive prenatal testing of fetal nucleated red blood cells, derived from maternal peripheral blood
Stem Cell Separation:
- Transplant preparation from patient or donor
- Purging of transplants for autologous use in
patients with malignancies
Umbilical cord blood processing
Purification of hematopoietic sub-populations
for diagnostic tests
Tracking of tumor cells in the body
Cell isolation and rare cell detection
Insight CEP yields significantly more viable cells than current cell separation methods with little or no structural or membrane changes in the harvested cells.
Commitment
BioCep's team of leading medical professionals and engineers is committed to developing lifesaving applications based on its superior technology.
Innovation CEP's separation abilities are unsurpassed. It is this novelty that will enable breakthroughs in fields such as non-invasive prenatal testing, stem cell transplant, and diagnostic testing.
Insight